House Passes Prescription Drug Safety Reforms
Senate to follow
The House today passed significant reforms to the Food and Drug Administration’s drug safety review system. Part of a comprehensive FDA bill, the bill was a compromise between Senate and House legislation that passed overwhelmingly earlier this year. The bill, which includes strong consumer protections, will be voted on in the Senate tomorrow.
Statement by CALPIRG’s Federal Health Care Advocate Paul Brown: